Germline Mutation Prevalence in Consecutive, Unselected Individuals with Pancreatic Adenocarcinoma
The prevalence of germline mutations in unselected patients with pancreatic ductal adenocarcinoma was found to be 12% in this study.
Prior studies investigating mutation prevalence have provided estimates of prevalence but have primarily been carried out on selected groups of pancreatic cancer patients.